Skip to content
Fineotex Chemical logo

Fineotex Chemical

FCL NSE
₹53.42 +4.27 (+8.69%)
P/E
50.40
View as Markdown
MCP
Close 4 Nov 2026 ₹53.42 +27.97 +110% 1Y
Start ₹25.45

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
18.30%
Debt to Equity
0.01
EPS (TTM)
₹1.06
Book Value
₹7.58
Market Cap
—
P/E (TTM)
50.40
P/B
7.05
ROE
13.50%
Dividend Yield
1.73%
EBITDA
₹168 Cr
52W High
₹62.40
52W Low
₹19.10
Day Range
₹49.00 – ₹53.80
Volume
2,35,85,082

Peer Comparison

Commodities › Chemicals › Specialty Chemicals

Fineotex Chemical peer comparison
Pidilite Industries
₹1,510.2058.04₹1,54,107 Cr13.721.42%23.90%31.00%₹15,399 Cr₹2,677 Cr
Gujarat Fluorochemicals
₹4,613.3083.76₹49,073 Cr6.040.07%7.82%9.64%₹5,303 Cr₹600 Cr
Navin Fluorine International
₹8,785.0057.03₹44,060 Cr10.100.09%19.60%21.00%₹3,634 Cr₹789 Cr
Deepak Nitrite
₹1,578.4027.48₹20,919 Cr3.320.49%9.82%11.40%₹8,575 Cr₹784 Cr
Aether Industries
₹1,540.7086.90₹20,030 Cr7.880.00%9.66%11.90%₹1,231 Cr₹235 Cr
Aarti Industries
₹447.5530.57₹15,838 Cr2.590.23%7.13%6.86%₹9,010 Cr₹531 Cr
Atul
₹5,156.5019.67₹14,827 Cr2.310.59%11.50%14.90%₹6,969 Cr₹788 Cr
Fineotex Chemical (this company)
₹53.4250.40₹5,797 Cr7.051.73%13.50%18.30%₹1,012 Cr₹148 Cr
Median 8 companies₹1,559.5553.72₹20,474 Cr6.550.36%10.66%13.40%₹6,136 Cr₹692 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

61 Good

Data confidence 100/100

Category scores

Quality
50
Average
Returns, margins, earnings quality 22% weight
Valuation
38
Weak
Cheap vs sector & own history 24% weight
Growth
99
Strong
Sales & profit trajectory 9% weight
Financial Health
90
Strong
Solvency, leverage, coverage 9% weight
Momentum
99
Strong
Trend strength, vol-adjusted 12% weight
Ownership
43
Weak
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 23.8%

Weaknesses

2
  • Stock is trading at 7.50 times its book value
  • Debtor days have increased from 102 to 137 days.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish469
OscillatorsBearish360
Moving AveragesStrong Bullish109

Key readings

RSI (14)
51.89
Neutral
MACD (12,26,9)
−1.32
Bearish
SMA (50)
53.94
Bearish
SMA (200)
36.53
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+21.51%
5Y+28.66%
3Y+14.30%
1Y+44.84%
TTM+91.49%

Net profit

Net profit growth by window
10Y+20.11%
5Y+22.67%
3Y+11.57%
1Y+14.68%
TTM+40.95%

Operating cash flow

Operating cash flow growth by window
10YTurned negative
5YTurned negative
3YTurned negative
1YTurned negative
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−7.96 pp
5Y−1.23 pp
3Y−4.37 pp
1Y−6.34 pp
TTM−5.25 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹127 Cr
Mar 2018₹141 Cr
Mar 2019₹182 Cr
Mar 2020₹196 Cr
Mar 2021₹219 Cr
Mar 2022₹368 Cr
Mar 2023₹517 Cr
Mar 2024₹569 Cr
Mar 2025₹533 Cr
Mar 2026₹772 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹29.00 Cr
Mar 2018₹24.00 Cr
Mar 2019₹24.00 Cr
Mar 2020₹14.00 Cr
Mar 2021₹45.00 Cr
Mar 2022₹57.00 Cr
Mar 2023₹90.00 Cr
Mar 2024₹121 Cr
Mar 2025₹109 Cr
Mar 2026₹125 Cr

Analyst Forecasts

Forecast For
Mar 27 consensus · Price
₹28.00 −51.3% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Generated 31 Jul 2026
AI opinion · based on fundamentals
Risk medium

Fineotex Chemical Ltd is a nearly debt-free specialty chemicals company with a market cap of ₹4,489 Cr trading at a P/E of 29.8x. The company delivered strong TTM sales growth of 91% (driven by Q4 FY26 revenue up 162% YoY to ₹313.7 Cr), though FY25 consolidated PAT declined 9.8% YoY to ₹109 Cr and ROE has compressed from a 5-year average of 21% to 13% in the last year.

Bull Case 7
  • Near debt-free balance sheet provides financial flexibility and low interest burden (interest cost just ₹0.53 Cr in FY25 vs operating profit of ₹81+ Cr)
  • Q4 FY26 consolidated revenue surged 162% YoY to ₹313.7 Cr, signaling strong demand recovery and possible inflection in growth trajectory
  • TTM compounded sales growth of 91% is significantly ahead of the 10-year CAGR of 22%, indicating accelerating top-line momentum
  • 10-year compounded profit CAGR of 20% and 10-year stock CAGR of 31% demonstrate long-term consistent value creation
  • 5-year average ROE of 21% reflects efficient capital deployment over a meaningful time period
  • P/B ratio of 4.99x is supported by consistently high return ratios (5-year ROE of 21%), suggesting the premium is backed by earnings quality
  • Company is expected to deliver a good upcoming quarter per market consensus, building on the Q4 FY26 momentum
Bear Case 7
  • Debtor days have increased sharply from 102 to 137 days, indicating deteriorating working capital efficiency and potential collection risk
  • FY25 consolidated PAT declined to ₹109.2 Cr from ₹121 Cr in FY24, a fall of approximately 9.8% YoY despite revenue being largely flat
  • Last year ROE compressed to 13% from a 5-year average of 21%, representing a 38% decline in return on equity
  • 3-year compounded profit CAGR of only 7% lags the 3-year sales CAGR of 14%, suggesting margin pressure and inability to convert revenue growth into proportional profit growth
  • P/E of 29.8x is elevated relative to the recent profit growth of 7% (3-year CAGR), implying a PEG ratio well above 1x
  • FY25 consolidated PBT fell to ₹141.2 Cr from ₹157.6 Cr in FY24, showing pre-tax margin compression from roughly 27% to 25%
  • TTM profit growth of 17% materially trails TTM sales growth of 91%, raising questions about operating leverage and cost discipline at scale

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

94d ago

TL;DR: Fineotex Chemical delivered an exceptionally strong Q1FY27 with PAT nearly doubling and volumes more than doubling, signalling robust demand and operational execution. No headwinds are visible in recent coverage. The trend is clearly improving, and the upcoming earnings call on Jul 24 may provide further clarity on sustainability of this growth trajectory.

Positives 1
  • Q1FY27 PAT surges 93% Jul 23

    Consolidated PAT jumped 92.61% to ₹4,821 Lakhs in Q1FY27, backed by 164.48% revenue growth and 130.84% volume growth. Statutory auditors issued an unqualified review report, indicating clean financials.

Neutral 1
  • Q1 FY27 earnings call scheduled Jul 20

    Fineotex Chemical will host an analyst conference call on July 24, 2026 at 5:00 PM IST to discuss Q1 FY27 results.

Quarterly Results

₹ Cr
FCL quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
132
145
138
153
142
146
126
120
137
138
184
314
377
Expenses
101
107
98
115
107
109
92
99
112
107
149
270
317
Operating Profit
32
38
40
38
35
36
34
21
25
31
35
44
59
OPM %
24%
26%
29%
25%
25%
25%
27%
18%
18%
23%
19%
14%
16%
Other Income
4
4
5
4
5
7
5
8
9
8
7
9
10
Interest
0
0
0
1
0
0
0
0
0
0
0
1
0
Depreciation
1
1
1
2
2
2
3
2
3
3
3
4
4
PBT
34
40
44
40
38
41
36
26
31
35
38
48
65
Tax %
22%
22%
24%
24%
22%
21%
24%
24%
21%
26%
21%
9%
26%
Net Profit
26
31
33
30
29
32
28
20
25
26
30
44
48
EPS (₹)
0.23
0.28
0.29
0.27
0.26
0.28
0.24
0.17
0.22
0.23
0.23
0.27
0.33

Profit & Loss

₹ Cr
FCL profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
102
110
127
141
182
196
219
368
517
569
533
772
1,012
Expenses
85
82
98
111
148
162
178
297
404
421
406
637
843
Operating Profit
16
28
29
30
34
35
41
71
113
148
127
135
169
OPM %
16%
26%
23%
21%
19%
18%
19%
19%
22%
26%
24%
17%
17%
Other Income
5
2
10
5
1
−11
17
6
7
17
24
33
34
Interest
0
0
0
1
1
1
1
1
1
1
1
1
1
Depreciation
0
1
1
1
1
1
1
3
4
6
9
13
15
PBT
20
29
38
34
34
22
56
73
115
158
141
153
186
Tax %
28%
31%
24%
29%
28%
35%
20%
22%
22%
23%
23%
18%
—
Net Profit
15
20
29
24
24
14
45
57
90
121
109
125
148
EPS (₹)
0.11
0.16
0.23
0.2
0.2
0.12
0.38
0.5
0.8
1.08
0.94
0.93
1.06
Div. Payout %
9%
13%
4%
10%
5%
4%
8%
8%
10%
15%
8%
48%
—

Balance Sheet

₹ Cr
FCL balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
22
22
22
22
22
22
22
22
22
22
23
116
Reserves
54
69
90
113
137
147
187
240
327
425
708
766
Borrowings
2
3
1
5
2
3
3
2
7
5
0
8
Other Liabilities
23
20
26
21
34
35
54
75
67
96
83
269
Total Liabilities
101
114
140
161
195
208
267
339
423
548
815
1,159
Fixed Assets
18
19
27
29
36
41
59
84
99
141
179
278
CWIP
0
0
0
0
0
1
5
0
0
0
21
2
Investments
29
39
47
55
48
52
32
17
89
147
330
317
Other Assets
54
56
66
77
110
114
171
238
234
260
284
562
Total Assets
101
114
140
161
195
208
267
339
423
548
815
1,159

Cash Flow

₹ Cr
FCL cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
14
14
19
6
12
28
9
13
107
97
69
−24
Investing
−14
−13
−14
−6
5
−19
−7
1
−99
−47
−273
113
Financing
−3
−1
−6
−4
−3
−4
−4
−6
−6
−24
176
−63
Net Cash Flow
−3
−1
−1
−3
14
6
−2
8
1
26
−27
27
Free Cash Flow
8
12
14
4
4
22
−15
−9
88
49
1
−49
CFO/OP
109
84
104
52
63
104
46
43
119
92
77
0

Ratios

FCL financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
80
84
84
72
98
100
138
110
72
89
79
137
Inventory Days
56
66
70
97
84
66
79
98
53
55
75
112
Days Payable
75
75
82
50
70
73
101
96
53
79
66
117
Cash Conversion Cycle
60
75
72
119
112
93
116
111
72
64
88
133
Working Capital Days
58
73
73
114
118
107
136
125
71
76
104
140
ROCE %
21%
31%
35%
26%
22%
20%
28%
30%
36%
39%
24%
18%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Fineotex Chemical insights

64 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 62.30%
  • Public 29.83%
  • Others 4.22%
  • FIIs 2.01%
  • DIIs 1.64%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Fineotex Chemical

What does Fineotex Chemical Ltd do?
Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries
Where is Fineotex Chemical Ltd (FCL) listed?
Fineotex Chemical Ltd trades as FCL on the NSE and under code 533333 on the BSE.
Which sector does Fineotex Chemical Ltd belong to?
Fineotex Chemical Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the PE ratio of Fineotex Chemical Ltd?
Fineotex Chemical Ltd trades at a PE ratio of 50.40 as of 4 Nov 2026, on earnings per share of ₹1.06, against a book value of ₹7.58 per share.
What is the 52-week high and low of Fineotex Chemical Ltd?
Over the last 52 weeks Fineotex Chemical Ltd has traded between ₹19.1 and ₹62.4 as of 4 Nov 2026.
Does Fineotex Chemical Ltd pay dividends?
Fineotex Chemical Ltd has a dividend yield of 1.73%.
What is the Return on Equity (ROE) of Fineotex Chemical Ltd?
Fineotex Chemical Ltd reported a return on equity of 13.50%. Its debt-to-equity ratio is 0.01.

Company Information

Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries

Website fineotex.com
CEO Mr. Surendrakumar Deviprasad Tibrewala B.Com, LLB
Employees 210
Listed 15 Jan 2015
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FCL.md for Fineotex Chemical Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month